Envista (NVST) - EV/EBITDA Multiple

Nobel Biocare - graphic logo of issuer NVST

The EV/EBITDA multiple for Envista Holdings (NVST), adjusted for debt load and reflecting the risks of the company's dependence on aesthetic dentistry and logistics, has settled at 9.85. A decline in consumer spending on implants and pressure from low-cost alternatives are weighing on revenue. However, patent protection and strict FDA regulations create significant barriers to entry for new players in this sector.

NVST Envista Holdings Corp: Enterprise Value to Operating Income Before Depreciation in the range 11/23/2025 - 11/16/2026

Analytical breakdowns for Envista Holdings Corporation (NVST)

- stock price and consensus target price:
Summary company analysis:Nobel Biocare (NVST)
Manufactured products of Envista

Positioned at a cyclical bottom in the dental equipment market, Envista Holdings (NVST) is facing a temporary decline in demand, which directly impacts the denominator of the formula through lower operating profit. The enterprise value to EBITDA ratio measures the company's ability to service debt and taxes; therefore, the historical EV/EBITDA value allows an investor to assess the margin of safety and identify a cheap entry point into the asset.

Competitors of Envista Holdings

Intuitive Surgical - Enterprise Value to EBITDA Ratio|Total Company Value to Operating Income Before Depreciation Ratio danaher.com (DHR)|BDX - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|STE (STERIS PLC) - Enterprise Value to Operating Income Before Depreciation|West Pharma Corp (WST) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|BAX - Total Company Value to Operating Income Before Depreciation Ratio|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization masimo.com|Stevanato Group (STVN) - Total Company Value to Operating Income Before Depreciation Ratio|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Teleflex (TFX)|Enterprise Value to Operating Income Before Depreciation Ratio MMSI|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization ICU Medical Corp ICUI|Business Value to Operating Income Before Depreciation XRAY|LMAT: Enterprise Value to EBITDA Ratio|ATRC - EV/EBITDA Multiple|STAAR Surgical Co. (STAA) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Enterprise Value to EBITDA Ratio ChromaDex Corp.|ZIMV (zimvie.com) - EV/EBITDA Multiple|Company Value to EBITDA AngioDynamics Inc. ANGO|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Cerus (CERS)|Teknova - Enterprise Value to Operating Income Before Depreciation|Monogram Technologies - Enterprise Value to EBITDA Ratio|Enterprise Value to Operating Income Before Depreciation Ratio STSS (Sharps Technology, Inc.)|INFU - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Total Company Value to Operating Income Before Depreciation Ratio Utah Medical Products UTMD|KORU Medical (KRMD) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Enterprise Value to Operating Income Before Depreciation NYXH|MBOT (Microbot Medical, Inc.) - EV/EBITDA Multiple|PDEX: Business Value to Operating Income Before Depreciation|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Zentek Ltd. (ZTEK)|EV/EBITDA Multiple Elutia Inc. (ELUT)|EV/EBITDA Multiple MLSS (Milestone Scientific Inc)|Enterprise Value to EBITDA Multiple NEXGEL, Inc.|Retractable Technologies, Inc. - EV/EBITDA Multiple|HBIO - EV/EBITDA Multiple|FEMY (femasys.com) - Enterprise Value to EBITDA Ratio|Meihua Medical (MHUA) - EV/EBITDA Multiple|Enterprise Value to EBITDA Ratio POAI|CJMB: Business Value to Operating Income Before Depreciation|EV/EBITDA Multiple ATRI|Enterprise Value to Operating Income Before Depreciation Ratio NURO